The methylation rate of the NDRG2 promoter region is significantly higher in glioma, HCC, meningioma, and gastric carcinoma tissues compared with adjacent normal tissues, which may down-regulate NDRG2 [11, 52, 60, 64, 75, 121]. The gene discussed is NDRG2; the disease is central nervous system cancer.